← All candidates
168 insider filings on record.
Gilbert Ray Cisneros, Jr.Small Business · Armed Servicestraded 9 Mar · filed 7 Apr · selfBought$1K–$15Kself9 Mar192d ago7 Apr163d ago168 filings on record.
HALOHALOZYME THERAPEUTICS, INC.
NasdaqGS · Healthcare · $12.31B
$108.44
+2.06% today
168 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 67 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$12.31B
Float
112.2M
99% public
Short % float
Pro
Price / profit
31.8
Price / future profit
10.4
Price / sales
7.4
Congress
▸ Disclosures lag trades by 30–45 days.
1 disclosure12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
163 more transactions on Pro →Context
Wall St
$99.56 avg target
-8.2% vs today · 9 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q2 '26$2.28 act+$0.46
Q1 '26$1.60 act+$0.08
Q4 '25−$0.24 act−$2.44
Q3 '25$1.72 act+$0.09
Coverage
Halozyme Investor Conferences Put ENHANZE and Expanded Drug Delivery Portfolio in FocusInvestorsHub · 2w agoIf You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth NowZacks · 2w agoIs Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks · 2w agoTight Action In HALO Stock Sets Up Heavenly GainsInvestor's Business Daily · 2w ago
The file stays open
168 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice